Adam Price, MD
Clinical Cardiac Electrophysiology · Live Oak, TXNPI 1548447196
Payments from drug & device makers
Across 265 payments — averaging $34.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$2K
- Boston Scientific$1K
- Medical Device Business Services, Inc.$1K
- Acutus Medical, Inc.$740
- Medtronic$705
- Johnson & Johnson$601
- plus $3K from 28 others
What the payments were for
- Travel & lodging$1,02411%
- Food & beverage$8,09988%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 82 | $2,206 |
| Boston Scientific | 39 | $1,151 |
| Medical Device Business Services, Inc. | 5 | $1,024 |
| Acutus Medical, Inc. | 5 | $740 |
| Medtronic(2 entities) | 18 | $705 |
| Johnson & Johnson | 20 | $601 |
| Amgen | 9 | $460 |
| Abbott | 10 | $371 |
| Pfizer | 21 | $353 |
| Cvrx, Inc. | 2 | $221 |
| Atricure, Inc. | 2 | $205 |
| Biotronik Inc. | 7 | $149 |
| Novartis | 8 | $145 |
| Novo Nordisk | 1 | $125 |
| Sanofi-aventis U.S. LLC | 6 | $107 |
| E.r. Squibb & Sons, L.L.C. | 6 | $92 |
| Merck | 1 | $70 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $69 |
| Esperion Therapeutics, Inc. | 4 | $69 |
| Catheter Precision Inc. | 1 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Cordis US CORP. | 1 | $20 |
| Altathera Pharmaceuticals LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Medicomp Inc | 1 | $19 |
| Cardiva Medical, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| G Medical Diagnostic Services, Inc. | 1 | $13 |
| Philips North America LLC | 1 | $11 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,692
- Repatha$372
- XARELTO$248
- GALLANT$192
- ATRICLIP LAA EXCLUSION SYSTEM$156
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$156
- CONFIDENCE SPINAL CEMENT SYSTEM$137
- Barostim Neo System$130
- BodyGuardian$127
- Azure$125
- Wegovy$125
- Carto 3 System$122
- Smartablate$117
- CartoSound$110
- Micra$109
- Farapulse$105
How this compares
$9,175 in reported general payments places this provider in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 387 | $462,045 |
| MultaqDronedarone Hcl | 145 | $180,891 |
| XareltoRivaroxaban | 151 | $166,929 |
| Dofetilide | 136 | $24,805 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 22 | $7,705 |
| Amiodarone Hcl | 190 | $4,991 |
| Metoprolol Succinate | 276 | $4,498 |
| Flecainide Acetate | 151 | $4,385 |
| Diltiazem 12hr ErDiltiazem Hcl | 12 | $3,473 |
| SotalolSotalol Hcl | 102 | $1,550 |
| Propafenone Hcl | 21 | $879 |
| Metoprolol Tartrate | 100 | $700 |
| Warfarin Sodium | 63 | $553 |
| Propranolol Hcl | 11 | $515 |
| Diltiazem Hcl | 17 | $442 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $353 | $462,045387 claims |
| Sanofi-aventis U.S. LLCMultaq | $107 | $180,891145 claims |
| Johnson & JohnsonXarelto | $601 | $166,929151 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Live Oak
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- James DevillePlano$1.5M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
- Miguel ValderrabanoHouston$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.